These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34239372)

  • 1. Association of Alopecia Areata With Attention-Deficit/Hyperactivity Disorder Stimulant Medication: A Case-Control Study.
    Meaux TA; McMahon PM; Jones GN; Bush AE; Kennedy JJ; Poche GW
    Ochsner J; 2021; 21(2):139-142. PubMed ID: 34239372
    [No Abstract]   [Full Text] [Related]  

  • 2. Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.
    Uzuncakmak TK; Engin B; Serdaroglu S; Tuzun Y
    Skin Appendage Disord; 2021 Jan; 7(1):8-12. PubMed ID: 33614711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Alopecia Areata Risk in Children with Attention-Deficit/Hyperactivity Disorder and the Impact of Methylphenidate Use: A Nationwide Population-Based Cohort Study.
    Ho HY; Wong CK; Wu SY; Hsiao RC; Chen YL; Yen CF
    Int J Environ Res Public Health; 2021 Feb; 18(3):. PubMed ID: 33535410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
    Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
    JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of the Risk of Alopecia Areata Progressing to Alopecia Totalis and Alopecia Universalis: Biomarker Development with Bioinformatics Analysis and Machine Learning.
    Zhang T; Nie Y
    Dermatology; 2022; 238(2):386-396. PubMed ID: 34004600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune, Inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers With Alopecia Areata.
    Lee JY; Ju HJ; Han JH; Lee JH; Bae JM; Lee WS; Lee S
    JAMA Dermatol; 2023 Jul; 159(7):711-719. PubMed ID: 37223925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency of fatty liver in patients with alopecia areata: A case-control study.
    Tehranchinia Z; Abdollahimajd F; Haghighatkhah H; Talebi A; Yarahmadi A; Zoghi G
    J Cosmet Dermatol; 2023 Sep; 22(9):2579-2583. PubMed ID: 37017934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma in alopecia areata.
    Arca E; Muşabak U; Akar A; Erbil AH; Taştan HB
    Eur J Dermatol; 2004; 14(1):33-6. PubMed ID: 14965793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in patients with Alopecia Areata: A case-control study.
    Abdollahimajd F; Niknezhad N; Bahreini N; Younespour S; Namazi N
    Dermatol Ther; 2021 Jul; 34(4):e14979. PubMed ID: 33991033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata.
    Ray M; Swallow E; Gandhi K; Carley C; Sikirica V; Wang T; Done N; Signorovitch J; Mostaghimi A
    J Health Econ Outcomes Res; 2022; 9(2):11-18. PubMed ID: 35975139
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database.
    George P; Jagun O; Liu Q; Wentworth C; Napatalung L; Wolk R; Anway S; Zwillich SH
    Dermatol Ther (Heidelb); 2023 Aug; 13(8):1733-1746. PubMed ID: 37296372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database.
    George P; Jagun O; Liu Q; Wentworth C; Napatalung L; Wolk R; Anway S; Zwillich SH
    J Dermatol; 2023 Sep; 50(9):1121-1128. PubMed ID: 37291688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and immunological studies on erythrocytes superoxide dismutase modified by nitric oxide in patients with alopecia areata: Implications in alopecia patchy persistent and alopecia universalis.
    Rasheed Z; Alzolibani AA; Al-Shobaili HA; Saif GB; Al Robaee AA
    Immunol Lett; 2014 Jul; 160(1):50-57. PubMed ID: 24694751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.
    Choi SM; Kang MJ; Kwon SH; Sim WY; Lew BL
    J Dermatol; 2023 Oct; 50(10):1335-1338. PubMed ID: 37208851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe subtype of alopecia areata is highly associated with thyroid autoimmunity.
    Bin Saif GA
    Saudi Med J; 2016 Jun; 37(6):656-61. PubMed ID: 27279512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha in patients with alopecia areata.
    Kasumagic-Halilovic E; Prohic A; Cavaljuga S
    Indian J Dermatol; 2011; 56(5):494-6. PubMed ID: 22121261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall and Racial and Ethnic Subgroup Prevalences of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.
    Sy N; Mastacouris N; Strunk A; Garg A
    JAMA Dermatol; 2023 Apr; 159(4):419-423. PubMed ID: 36857044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
    Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
    Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of systemic minoxidil and tofacitinib combination in treatment-resistant alopecia universalis.
    Dincer D; Tanacan E; Kose Ozkan C
    J Cosmet Dermatol; 2021 Jun; 20(6):1807-1809. PubMed ID: 33098729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient.
    Ramot Y; Zlotogorski A
    Skin Appendage Disord; 2018 Apr; 4(2):122-124. PubMed ID: 29765973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.